HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial

NCT04833023 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Haloperidol
Advanced Cancer
Hyperactive Delirium
Olanzapine
End-stage Organ Disease

Interventions

DRUG: Haldol 2mg/ml oral solution
DRUG: Olanzapine Actavis 5mg orodispersible tablet

Sponsor

Tan Tock Seng Hospital